Literature DB >> 33008494

Harnessing Natural Killer Cell Function for Genitourinary Cancers.

Nina Bhardwaj1, Adam M Farkas2, Zeynep Gul3, John P Sfakianos4.   

Abstract

Natural killer (NK) cells are potently cytolytic innate lymphocytes involved in the immune surveillance of tumors and virally infected cells. Although much progress has been made in manipulating the ability of T cells to recognize and eliminate tumors, a comprehensive understanding of NK-cell infiltration into solid tumors, and their amenability to immunomodulation, remains incomplete. This article discusses recent studies showing that urologic tumors are infiltrated by NK cells and that these NK cells are often dysfunctional, but that strategies interfering with inhibitory axes have significant potential to alleviate this dysfunction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Genitourinary cancer; Immunotherapy; NK cells; Natural killer cells; RCC; Renal cancer

Mesh:

Year:  2020        PMID: 33008494      PMCID: PMC7992041          DOI: 10.1016/j.ucl.2020.07.002

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  50 in total

1.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

2.  NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.

Authors:  Petra U Prinz; Anna N Mendler; Dorothee Brech; Ilias Masouris; Ralph Oberneder; Elfriede Noessner
Journal:  Int J Cancer       Date:  2014-03-26       Impact factor: 7.396

3.  Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.

Authors:  Padmanee Sharma; Margitta Retz; Arlene Siefker-Radtke; Ari Baron; Andrea Necchi; Jens Bedke; Elizabeth R Plimack; Daniel Vaena; Marc-Oliver Grimm; Sergio Bracarda; José Ángel Arranz; Sumanta Pal; Chikara Ohyama; Abdel Saci; Xiaotao Qu; Alexandre Lambert; Suba Krishnan; Alex Azrilevich; Matthew D Galsky
Journal:  Lancet Oncol       Date:  2017-01-26       Impact factor: 41.316

4.  The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro.

Authors:  Matthias Krusch; Julia Salih; Manuela Schlicke; Tina Baessler; Kerstin Maria Kampa; Frank Mayer; Helmut Rainer Salih
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

5.  Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Authors:  Christine Pasero; Gwenaëlle Gravis; Mathilde Guerin; Samuel Granjeaud; Jeanne Thomassin-Piana; Palma Rocchi; Maria Paciencia-Gros; Flora Poizat; Mélanie Bentobji; Francine Azario-Cheillan; Jochen Walz; Naji Salem; Serge Brunelle; Alessandro Moretta; Daniel Olive
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

6.  Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis.

Authors:  T J Christmas
Journal:  Br J Urol       Date:  1994-05

7.  Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.

Authors:  François Audenet; Adam M Farkas; Harry Anastos; Matthew D Galsky; Nina Bhardwaj; John P Sfakianos
Journal:  World J Urol       Date:  2018-06-02       Impact factor: 4.226

Review 8.  NK cells for cancer immunotherapy.

Authors:  Noriko Shimasaki; Amit Jain; Dario Campana
Journal:  Nat Rev Drug Discov       Date:  2020-01-06       Impact factor: 84.694

9.  Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.

Authors:  Marie Lundholm; Mona Schröder; Olga Nagaeva; Vladimir Baranov; Anders Widmark; Lucia Mincheva-Nilsson; Pernilla Wikström
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

10.  Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer.

Authors:  Neelam Mukherjee; Niannian Ji; Vincent Hurez; Tyler J Curiel; Maureen O Montgomery; Andrew J Braun; Marlo Nicolas; Marcela Aguilera; Dharam Kaushik; Qianqian Liu; Jianhua Ruan; Kerri A Kendrick; Robert S Svatek
Journal:  Oncotarget       Date:  2018-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.